Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. · Phase II
708 (USA) · Dr. Kim
consented 2013-12-26
AEs
2
Serious
0
Dropout signal
–
Adverse events
mild
assessed
Mild OEDEMA PERIPHERAL — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-06-16 (study day 173.0); relationship: NONE
mild
assessed
Mild OEDEMA PERIPHERAL — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-06-16 (study day 173.0); relationship: NONE
Data queries
No data queries.